Rascon-Cruz Q, Espinoza-Sanchez EA, Siqueiros-Cendon TS, Nakamura-Bencomo SI, Arévalo-Gallegos S and Iglesias-Figueroa BF: Lactoferrin: A glycoprotein involved in immunomodulation, anticancer, and antimicrobial processes. Molecules. 26:2052021. View Article : Google Scholar

Baker EN, Baker HM and Kidd RD: Lactoferrin and transferrin: Functional variations on a common structural framework. Biochem Cell Biol. 80:27–34. 2002. View Article : Google Scholar

Lambert LA, Perri H and Meehan TJ: Evolution of duplications in the transferrin family of proteins. Comp Biochem Physiol B Biochem Mol Biol. 140:11–25. 2005. View Article : Google Scholar

Pierce A, Legrand D and Mazurier J: Lactoferrin: A multifunctional protein. Med Sci (Paris). 25:361–369. 2009.In French. View Article : Google Scholar

Hao L, Shan Q, Wei J, Ma F and Sun P: Lactoferrin: Major physiological functions and applications. Curr Protein Pept Sci. 20:139–144. 2019. View Article : Google Scholar

Garcia-Montoya IA, Cendon TS, Arevalo-Gallegos S and Rascon-Cruz Q: Lactoferrin a multiple bioactive protein: An overview. Biochim Biophys Acta. 1820:226–236. 2012. View Article : Google Scholar

Legrand D, Pierce A, Elass E, Carpentier M, Mariller C and Mazurier J: Lactoferrin structure and functions. Adv Exp Med Biol. 606:163–194. 2008. View Article : Google Scholar

Yanaihara A, Toma Y, Saito H and Yanaihara T: Cell proliferation effect of lactoferrin in human endometrial stroma cells. Mol Hum Reprod. 6:469–473. 2000. View Article : Google Scholar

Huang N, Bethell D, Card C, Cornish J, Marchbank T, Wyatt D, Mabery K and Playford R: Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth. In Vitro Cell Dev Biol Anim. 44:464–471. 2008. View Article : Google Scholar

Siebert PD and Huang BC: Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci USA. 94:2198–2203. 1997. View Article : Google Scholar

Klein G, Imreh S and Zabarovsky ER: Why do we not all die of cancer at an early age? Adv Cancer Res. 98:1–16. 2007. View Article : Google Scholar

Mariller C, Hardiville S, Hoedt E, Huvent I, Pina-Canseco S and Pierce A: Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor. Biochem Cell Biol. 90:307–319. 2012. View Article : Google Scholar

Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N and Moore MA: Cancer prevention by natural compounds. Drug Metab Pharmacokinet. 19:245–263. 2004. View Article : Google Scholar

Guedes JP, Pereira CS, Rodrigues LR and Corte-Real M: Bovine milk lactoferrin selectively kills highly metastatic prostate cancer PC-3 and osteosarcoma MG-63 cells in vitro. Front Oncol. 8:2002018. View Article : Google Scholar

Gonzalez-Chavez SA, Arevalo-Gallegos S and Rascon-Cruz Q: Lactoferrin: Structure, function and applications. Int J Antimicrob Agents. 33:301.e1–e8. 2009. View Article : Google Scholar

Actor JK, Hwang SA and Kruzel ML: Lactoferrin as a natural immune modulator. Curr Pharm Des. 15:1956–1973. 2009. View Article : Google Scholar

Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J and Nuijens JH: Lactoferrin is a lipid A-binding protein. Infect Immun. 62:2628–2632. 1994. View Article : Google Scholar

Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J and Spik G: Lactoferrin-lipopolysaccharide interaction: Involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J. 312:839–845. 1995. View Article : Google Scholar

Hu P, Zhao F, Wang J and Zhu W: Lactoferrin attenuates lipopolysaccharide-stimulated inflammatory responses and barrier impairment through the modulation of NF-kappaB/MAPK/Nrf2 pathways in IPEC-J2 cells. Food Funct. 11:8516–8526. 2020. View Article : Google Scholar

Baker HM and Baker EN: A structural perspective on lactoferrin function. Biochem Cell Biol. 90:320–328. 2012. View Article : Google Scholar

Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, Giannias B, Bourdeau F, Kubes P and Ferri L: Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 123:3446–3458. 2013. View Article : Google Scholar

van der Does AM, Hensbergen PJ, Bogaards SJ, Cansoy M, Deelder AM, van Leeuwen HC, Drijfhout JW, van Dissel JT and Nibbering PH: The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity. J Immunol. 188:5012–5019. 2012. View Article : Google Scholar

Park HW, Park SH, Jo HJ, Kim TG, Lee JH, Kang SG, Jang YS and Kim PH: Lactoferrin induces tolerogenic bone marrow-derived dendritic cells. Immune Netw. 20:e382020. View Article : Google Scholar

Eipper S, Steiner R, Lesner A, Sienczyk M, Palesch D, Halatsch ME, Zaczynska E, Heim C, Hartmann MD, Zimecki M, et al: Lactoferrin is an allosteric enhancer of the proteolytic activity of cathepsin G. PLoS One. 11:e1515092016. View Article : Google Scholar

Penco S, Scarfi S, Giovine M, Damonte G, Millo E, Villaggio B, Passalacqua M, Pozzolini M, Garrè C and Benatti U: Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem. 34:151–159. 2001. View Article : Google Scholar

Vogel HJ: Lactoferrin, a bird's eye view. Biochem Cell Biol. 90:233–244. 2012. View Article : Google Scholar

Takayama Y and Aoki R: Roles of lactoferrin on skin wound healing. Biochem Cell Biol. 90:497–503. 2012. View Article : Google Scholar

Kabanov AV and Batrakova EV: New technologies for drug delivery across the blood brain barrier. Curr Pharm Des. 10:1355–1363. 2004. View Article : Google Scholar

Elzoghby AO, Abdelmoneem MA, Hassanin IA, Abd Elwakil MM, Elnaggar MA, Mokhtar S, Fang JY and Elkhodairy KA: Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand. Biomaterials. 263:1203552020. View Article : Google Scholar

Thangavel P, Ramachandran B, Chakraborty S, Kannan R, Lonchin S and Muthuvijayan V: Accelerated healing of diabetic wounds treated with L-Glutamic acid loaded hydrogels through enhanced collagen deposition and angiogenesis: An in vivo study. Sci Rep. 7:107012017. View Article : Google Scholar

Iigo M, Alexander DB, Long N, Xu J, Fukamachi K, Futakuchi M, Takase M and Tsuda H: Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie. 91:86–101. 2009. View Article : Google Scholar

Xu XX, Jiang HR, Li HB, Zhang TN, Zhou Q and Liu N: Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. J Dairy Sci. 93:2344–2350. 2010. View Article : Google Scholar

Wong SH, Francis N, Chahal H, Raza K, Salmon M, Scheel-Toellner D and Lord JM: Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid. Rheumatology (Oxford). 48:39–44. 2009. View Article : Google Scholar

Kruzel ML, Zimecki M and Actor JK: Lactoferrin in a context of inflammation-induced pathology. Front Immunol. 8:14382017. View Article : Google Scholar

Bournazou I, Pound JD, Duffin R, Bournazos S, Melville LA, Brown SB, Rossi AG and Gregory CD: Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest. 119:20–32. 2009.

Bezault J, Bhimani R, Wiprovnick J and Furmanski P: Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res. 54:2310–2312. 1994.PubMed/NCBI

Damiens E, Mazurier J, el Yazidi I, Masson M, Duthille I, Spik G and Boilly-Marer Y: Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta. 1402:277–287. 1998. View Article : Google Scholar

Shi H and Li W: Inhibitory effects of human lactoferrin on U14 cervical carcinoma through upregulation of the immune response. Oncol Lett. 7:820–826. 2014. View Article : Google Scholar

Iyer S, Yip TT, Hutchens TW and Lonnerdal B: Lactoferrin-receptor interaction. Effect of surface exposed histidine residues. Adv Exp Med Biol. 357:245–252. 1994. View Article : Google Scholar

Rastogi N, Singh A, Pandey SN, Sinha M, Bhushan A, Kaur P, Sharma S and Singh TP: Structure of the iron-free true C-terminal half of bovine lactoferrin produced by tryptic digestion and its functional significance in the gut. FEBS J. 281:2871–2882. 2014. View Article : Google Scholar

Teng CT: Factors regulating lactoferrin gene expression. Biochem Cell Biol. 84:263–267. 2006. View Article : Google Scholar

Ieni A, Barresi V, Licata L, Cardia R, Fazzari C, Nuciforo G, Caruso F, Caruso M, Adamo V and Tuccari G: Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup. Oncol Lett. 13:3205–3209. 2017. View Article : Google Scholar

Tsuda H, Kozu T, Iinuma G, Ohashi Y, Saito Y, Saito D, Akasu T, Alexander DB, Futakuchi M, Fukamachi K, et al: Cancer prevention by bovine lactoferrin: From animal studies to human trial. Biometals. 23:399–409. 2010. View Article : Google Scholar

Gibbons JA, Kanwar RK and Kanwar JR: Lactoferrin and cancer in different cancer models. Front Biosci (Schol Ed). 3:1080–1088. 2011. View Article : Google Scholar

Digumarti R, Wang Y, Raman G, Doval DC, Advani SH, Julka PK, Parikh PM, Patil S, Nag S, Madhavan J, et al: A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer. J Thorac Oncol. 6:1098–1103. 2011. View Article : Google Scholar

Hoedt E, Hardiville S, Mariller C, Elass E, Perraudin JP and Pierce A: Discrimination and evaluation of lactoferrin and delta-lactoferrin gene expression levels in cancer cells and under inflammatory stimuli using TaqMan real-time PCR. Biometals. 23:441–452. 2010. View Article : Google Scholar

Zadvornyi TV, Lukianova NY, Borikun TV and Chekhun VF: Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro. Exp Oncol. 40:184–189. 2018. View Article : Google Scholar

Cutone A, Ianiro G, Lepanto MS, Rosa L, Valenti P, Bonaccorsi di Patti MC and Musci G: Lactoferrin in the prevention and treatment of intestinal inflammatory pathologies associated with colorectal cancer development. Cancers (Basel). 12:38062020. View Article : Google Scholar

Duchardt F, Ruttekolk IR, Verdurmen WP, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DW, Vuister GW, et al: A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J biol Chem. 284:36099–36108. 2009. View Article : Google Scholar

Riedl S, Leber R, Rinner B, Schaider H, Lohner K and Zweytick D: Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine. Biochim Biophys Acta. 1848:2918–2931. 2015. View Article : Google Scholar

Kühnle A, Veelken R, Galuska CE, Saftenberger M, Verleih M, Schuppe HC, Rudloff S, Kunz C and Galuska SP: Polysialic acid interacts with lactoferrin and supports its activity to inhibit the release of neutrophil extracellular traps. Carbohydr Polym. 208:32–41. 2019. View Article : Google Scholar

El YI, Legrand D, Nuijens J, Slomianny MC, van Berkel P and Spik G: The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus. Biochim Biophys Acta. 1568:197–204. 2001. View Article : Google Scholar

Jiang R and Lönnerdal B: Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways. Biochem Cell Biol. 95:99–109. 2017. View Article : Google Scholar

Sharma A, Shandilya UK, Sodhi M, Mohanty AK, Jain P and Mukesh M: Evaluation of milk colostrum derived lactoferrin of sahiwal (Bos indicus) and karan fries (Cross-Bred) cows for its anti-cancerous potential. Int J Mol Sci. 20:63182019. View Article : Google Scholar

Arias M, Hilchie AL, Haney EF, Bolscher JG, Hyndman ME, Hancock RE and Vogel HJ: Anticancer activities of bovine and human lactoferricin-derived peptides. Biochem Cell Biol. 95:91–98. 2017. View Article : Google Scholar

Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y, Yi W, Xiao L, Li X, Huang C, et al: Lactotransferrin: A candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. INT J Cancer. 123:2065–2072. 2008. View Article : Google Scholar

Onishi J, Roy MK, Juneja LR, Watanabe Y and Tamai Y: A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60). J Pept Sci. 14:1032–1038. 2008. View Article : Google Scholar

Lee SH, Park SW, Pyo CW, Yoo NK, Kim J and Choi SY: Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line. Biochimie. 91:102–108. 2009. View Article : Google Scholar

Fujita K, Matsuda E, Sekine K, Iigo M and Tsuda H: Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of Azoxymethane-treated rats. Carcinogenesis. 25:1961–1966. 2004. View Article : Google Scholar

Gopal SH and Das SK: Role of lactoferrin in the carcinogenesis of triple-negative breast cancer. J Cancer Clin Trials. 1:e1052016.

Velliyagounder K, Bahdila D, Pawar S and Fine DH: Role of lactoferrin and lactoferrin-derived peptides in oral and maxillofacial diseases. Oral Dis. 25:652–669. 2019. View Article : Google Scholar

Damiens E, El YI, Mazurier J, Duthille I, Spik G and Boilly-Marer Y: Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem. 74:486–498. 1999. View Article : Google Scholar

Ibrahim HM, Mohamed AH, Salem ML, Osman GY and Morsi DS: Anti-neoplastic and immunomodulatory potency of co-treatment based on bovine lactoferrin and/or muramyl dipeptide in tumor-bearing mice. Toxicol Res (Camb). 9:137–147. 2020. View Article : Google Scholar

Sangermano R, Pernarella S, Straker M, Lepanto MS, Rosa L, Cutone A, Valenti P and Ottolenghi L: The treatment of black stain associated with of iron metabolism disorders with lactoferrin: A litterature search and two case studies. Clin Ter. 170:e373–e381. 2019.PubMed/NCBI

Li HY, Li M, Luo CC, Wang JQ and Zheng N: Lactoferrin exerts antitumor effects by inhibiting angiogenesis in a HT29 human colon tumor model. J Agric Food Chem. 65:10464–10472. 2017. View Article : Google Scholar

Tammam SN, Azzazy H and Lamprecht A: Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin. Eur J Pharm Biopharm. 129:74–79. 2018. View Article : Google Scholar

Golla K, Bhaskar C, Ahmed F and Kondapi AK: A target-specific oral formulation of Doxorubicin-protein nanoparticles: Efficacy and safety in hepatocellular cancer. J Cancer. 4:644–652. 2013. View Article : Google Scholar

Sabra S and Agwa MM: Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications. Int J Biol Macromol. 164:1046–1060. 2020. View Article : Google Scholar

Song MM, Xu HL, Liang JX, Xiang HH, Liu R and Shen YX: Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery. Mater Sci Eng C Mater Biol Appl. 77:904–911. 2017. View Article : Google Scholar

Tomitaka A, Arami H, Gandhi S and Krishnan KM: Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging. Nanoscale. 7:16890–16898. 2015. View Article : Google Scholar

Zhang M, Asghar S, Tian C, Hu Z, Ping Q, Chen Z, Shao F and Xiao Y: Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma. Carbohydr Polym. 253:1171942021. View Article : Google Scholar

Yin Y, Fu C, Li M, Li X, Wang M, He L, Zhang LM and Peng Y: A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment. Mater Sci Eng C Mater Biol Appl. 67:159–169. 2016. View Article : Google Scholar

Guan Q: A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019:72472382019. View Article : Google Scholar

Frioni A, Conte MP, Cutone A, Longhi C, Musci G, di Patti MC, Natalizi T, Marazzato M, Lepanto MS, Puddu P, et al: Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases. Biometals. 27:843–856. 2014. View Article : Google Scholar

Sessa R, Di Pietro M, Filardo S, Bressan A, Rosa L, Cutone A, Frioni A, Berlutti F, Paesano R and Valenti P: Effect of bovine lactoferrin on chlamydia trachomatis infection and inflammation. Biochem Cell Biol. 95:34–40. 2017. View Article : Google Scholar

Valenti P, Frioni A, Rossi A, Ranucci S, De Fino I, Cutone A, Rosa L, Bragonzi A and Berlutti F: Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections. Biochem Cell Biol. 95:41–47. 2017. View Article : Google Scholar

Svendsen J, Grant TM, Rennison D, Brimble MA and Svenson J: Very short and stable lactoferricin-derived antimicrobial peptides: Design principles and potential uses. Acc Chem Res. 52:749–759. 2019. View Article : Google Scholar

Dial EJ, Romero JJ, Headon DR and Lichtenberger LM: Recombinant human lactoferrin is effective in the treatment of Helicobacter Felis-infected mice. J Pharm Pharmacol. 52:1541–1546. 2000. View Article : Google Scholar

Rodríguez-Franco DA, Vázquez-Moreno L and Ramos-Clamont MG: Antimicrobial mechanisms and potential clinical application of lactoferrin. Rev Latinoam Microbiol. 47:102–111. 2005.In Spanish.

Ellison RR and Giehl TJ: Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest. 88:1080–1091. 1991. View Article : Google Scholar

Dhaenens L, Szczebara F and Husson MO: Identification, characterization, and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori. Infect Immun. 65:514–518. 1997. View Article : Google Scholar

Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK and Swart PJ: Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 43:2635–2641. 1999. View Article : Google Scholar

Hakansson A, Roche H, Mirza S, McDaniel LS, Brooks-Walter A and Briles DE: Characterization of binding of human lactoferrin to pneumococcal surface protein A. Infect Immun. 69:3372–3381. 2001. View Article : Google Scholar

van der Strate BW, Beljaars L, Molema G, Harmsen MC and Meijer DK: Antiviral activities of lactoferrin. Antiviral Res. 52:225–239. 2001. View Article : Google Scholar

Campione E, Cosio T, Rosa L, Lanna C, Di Girolamo S, Gaziano R, Valenti P and Bianchi L: Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int J Mol Sci. 21:49032020. View Article : Google Scholar

Kell DB, Heyden EL and Pretorius E: The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front Immunol. 11:12212020. View Article : Google Scholar

Fu Q, Sun J, Zhang W, Sui X, Yan Z and He Z: Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov. 4:262–272. 2009. View Article : Google Scholar

Yi M, Kaneko S, Yu DY and Murakami S: Hepatitis C virus envelope proteins bind lactoferrin. J Virol. 71:5997–6002. 1997. View Article : Google Scholar

Bennett RM, Merritt MM and Gabor G: Lactoferrin binds to neutrophilic membrane DNA. Br J Haematol. 63:105–117. 1986. View Article : Google Scholar

He J and Furmanski P: Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature. 373:721–724. 1995. View Article : Google Scholar

Brandl N, Zemann A, Kaupe I, Marlovits S, Huettinger P, Goldenberg H and Huettinger M: Signal transduction and metabolism in chondrocytes is modulated by lactoferrin. Osteoarthritis Cartilage. 18:117–125. 2010. View Article : Google Scholar

Kanyshkova TG, Babina SE, Semenov DV, Isaeva N, Vlassov AV, Neustroev KN, Kul'minskaya AA, Buneva VN and Nevinsky GA: Multiple enzymic activities of human milk lactoferrin. Eur J Biochem. 270:3353–3361. 2003. View Article : Google Scholar

Fang JH, Lai YH, Chiu TL, Chen YY, Hu SH and Chen SY: Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas. Adv Healthc Mater. 3:1250–1260. 2014. View Article : Google Scholar

Wei M, Guo X, Tu L, Zou Q, Li Q, Tang C, Chen B, Xu Y and Wu C: Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma. Int J Nanomedicine. 10:5123–5137. 2015.PubMed/NCBI

Golla K, Cherukuvada B, Ahmed F and Kondapi AK: Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats. PLoS One. 7:e519602012. View Article : Google Scholar

Kumar P, Lakshmi YS, C B, Golla K and Kondapi AK: Improved safety, bioavailability and pharmacokinetics of zidovudine through lactoferrin nanoparticles during oral administration in rats. PLoS One. 10:e1403992015. View Article : Google Scholar

Kumari S and Kondapi AK: Receptor-mediated targeted delivery of DNA using Lactoferrin nanoparticles. Int J Biol Macromol. 108:401–407. 2018. View Article : Google Scholar

Elfinger M, Maucksch C and Rudolph C: Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials. 28:3448–3455. 2007. View Article : Google Scholar

Yan JK, Qiu WY, Wang YY and Wu JY: Biocompatible polyelectrolyte complex nanoparticles from lactoferrin and pectin as potential vehicles for antioxidative curcumin. J Agric Food Chem. 65:5720–5730. 2017. View Article : Google Scholar

Wang J, Li Q, Li K, Ou Y, Han Z, Gao D and Li J: Effects of adenovirus vectors mediated human lactoferrin cDNA on mice bearing EMT6 breast carcinoma. Pharmazie. 66:704–709. 2011.

Pereira CS, Guedes JP, Goncalves M, Loureiro L, Castro L, Gerós H, Rodrigues LR and Côrte-Real M: Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase. Oncotarget. 7:62144–62158. 2016. View Article : Google Scholar

Lonnerdal B, Jiang R and Du X: Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. J Pediatr Gastroenterol Nutr. 53:606–614. 2011. View Article : Google Scholar

Machado S, Alves R, Lima M, Leal I and Massa A: Cutaneous necrobiotic xanthogranuloma (NXG)-successfully treated with low dose chlorambucil. Eur J Dermatol. 11:458–462. 2001.PubMed/NCBI

Arcella A, Oliva MA, Staffieri S, Aalberti S, Grillea G, Madonna M, Bartolo M, Pavone L, Giangaspero F, Cantore G and Frati A: In vitro and in vivo effect of human lactoferrin on glioblastoma growth. J Neurosurg. 123:1026–1035. 2015. View Article : Google Scholar

Son HJ, Lee SH and Choi SY: Human lactoferrin controls the level of retinoblastoma protein and its activity. Biochem Cell Biol. 84:345–350. 2006. View Article : Google Scholar

Tung YT, Chen HL, Yen CC, Lee PY, Tsai HC, Lin MF and Chen CM: Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor. J Dairy Sci. 96:2095–2106. 2013. View Article : Google Scholar

Deng M, Zhang W, Tang H, Ye Q, Liao Q, Zhou Y, Wu M, Xiong W, Zheng Y, Guo X, et al: Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms. Oncogene. 32:4273–4283. 2013. View Article : Google Scholar

Chea C, Miyauchi M, Inubushi T, Febriyanti Ayuningtyas N, Subarnbhesaj A, Nguyen PT, Shrestha M, Haing S, Ohta K and Takata T: Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma. PLoS One. 13:e1916832018. View Article : Google Scholar

Sabra SA, Elzoghby AO, Sheweita SA, Haroun M, Helmy MW, Eldemellawy MA, Xia Y, Goodale D, Allan AL and Rohani S: Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer. Eur J Pharm Biopharm. 128:156–169. 2018. View Article : Google Scholar

Sabra SA, Sheweita SA, Haroun M, Ragab D, Eldemellawy MA, Xia Y, Goodale D, Allan AL, Elzoghby AO and Rohani S: Magnetically guided self-assembled protein micelles for enhanced delivery of dasatinib to human triple-negative breast cancer cells. J Pharm Sci. 108:1713–1725. 2019. View Article : Google Scholar

Abd Elwakil MM, Mabrouk MT, Helmy MW, Abdelfattah EA, Khiste SK, Elkhodairy KA and Elzoghby AO: Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma. Nanomedicine (Lond). 13:2015–2035. 2018. View Article : Google Scholar

Kumari S, Ahsan SM, Kumar JM, Kondapi AK and Rao NM: Overcoming blood brain barrier with a dual purpose Temozolomide loaded lactoferrin nanoparticles for combating glioma (SERP-17-12433). Sci Rep. 7:66022017. View Article : Google Scholar

Kumari S and Kondapi AK: Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy. Int J Biol Macromol. 95:232–237. 2017. View Article : Google Scholar

Wang H, Tang Y, Fang Y, Zhang M, Wang H, He Z, Wang B, Xu Q and Huang Y: Reprogramming Tumor Immune Microenvironment (TIME) and metabolism via biomimetic targeting Codelivery of Shikonin/JQ1. Nano Lett. 19:2935–2944. 2019. View Article : Google Scholar

Kumar P, Lakshmi YS and Kondapi AK: An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile. HIV Med. 18:452–462. 2017. View Article : Google Scholar

Zhang ZH, Wang XP, Ayman WY, Munyendo WL, Lv HX and Zhou JP: Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv. 20:86–93. 2013. View Article : Google Scholar

Shankaranarayanan JS, Kanwar JR, Al-Juhaishi AJ and Kanwar RK: Doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in TRAMP mice. Sci Rep. 6:320622016. View Article : Google Scholar